When you consider that IMM completed its capital raising at 2.1 cents only 6 weeks ago, a 62% rise in the share price is not an inconsiderable achievement, IMO.
There's always going to be some profit taking with every rise.
Todays announcement showed encouraging progress in an early stage clinical trial.
Good news certainly, but not earth shattering.
Talk of rockets need to wait for results from trials at their conclusion and regulatory approval for commercial sales.
Slowly slowly, catchee monkey.
.
Ann: New Data from Ongoing TACTI-mel Study, page-32
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 121215 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2864 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |